The trademark application was filed by Neurocrine Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 1, 2024, and still open for oppositions.
The application was filed in English (Italian was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for human use
Pharmaceutical preparations for the prevention and treatment of hormonal, genetic, and endocrine diseases, disorders, and conditions
Pharmaceutical preparations for human use for the treatment of rare and orphan diseases, disorders, and conditions
Pharmaceutical preparations for the treatment of congenital adrenal hyperplasia.